THE CANCER GENOME ATLAS Research Network, including more than 300 researchers from 44 institutions, found that molecular diagnostics are much more precise and reproducible than looking at tissue under a microscope for classification of diffuse gliomas.
MARY BECKERLE was appointed to the board of directors of Johnson & Johnson. Beckerle will serve on the board's Science, Technology & Sustainability Committee.
ROBERTO PILI joined the Indiana University Melvin and Bren Simon Cancer Center. Pili will direct the genitourinary research program at the cancer center and serve as the medical director of the genitourinary clinical program at the IU Health Simon Cancer Center.
NICOLE ROBINSON will lead the Industry Relations and Technology Transfer office at Fred Hutchinson Cancer Research Center. Robinson will begin her role as vice president of industry relations and business development on July 27.
THE COMMUNITY ONCOLOGY ALLIANCE announced that nine practices received accreditation as oncology medical homes through a pilot program by the Commission on Cancer.
THE DEPARTMENT OF DEFENSE appropriations bill for the 2016 fiscal year includes an additional $12 million for lung cancer research under the Congressionally Directed Medical Research Program. The bill has been approved by the House Appropriations Committee.
SHOHREH SHAHABI was named chief of the division of gynecologic oncology at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
ABBVIE completed its acquisition of Pharmacyclics Inc., includiing Imbruvica (ibrutinib).
VARIAN MEDICAL SYSTEMS and Flatiron Health will collaborate to develop electronic health record analytics and decision support software for cancer care providers. The goal is to offer a suite of cloud-based software solutions that support oncologists from screening to survivorship.
CATHERINE BROWN was named president of the John Wayne Cancer Foundation.
